1. Case Presentation {#sec1}
====================

In the present study, five cases of pulmonary nocardiosis (PN), four males and one female, were encountered among patients attending Vallabhbhai Patel Chest Institute, a tertiary care respiratory diseases hospital in Delhi, India. They were admitted with complaints of breathlessness and increased cough with sputum production from a week to 3-month duration. They all had fever and weight loss. All were immunocompromised with four of them having the chronic obstructive pulmonary disease (COPD) with tuberculosis and one with COPD and diabetes mellitus. Sputum samples from four and bronchial alveolar lavage, bronchial aspirate, and sputum from one case showed Gram-positive filamentous branching rods with beaded appearance on Gram\'s staining and acid fast branching filamentous rods with beaded appearance on modified Ziehl-Neelsen staining suggestive of*Nocardia*. It was isolated on sheep blood agar from four cases. Patients were treated with trimethoprim-sulfamethoxazole (TMP-SMX) along with other antibiotics like amikacin and imipenem/meropenem. Three were discharged and advised to continue TMP-SMX for six months. Two of these were followed up and were completely free of symptoms, and their sputum was negative on smear and culture. Two of the patients died. [Table 1](#tab1){ref-type="table"} shows the details of the cases.

2. Discussion and Update {#sec2}
========================

2.1. Introduction {#sec2.1}
-----------------

*Nocardia* is widely distributed in dust, soil, water, and vegetable matter. Inhalation of the dust particles leads to pulmonary involvement commonly caused by*N. asteroides* complex. Direct inoculation of the organism can lead to infections of the skin and subcutaneous tissue. They can disseminate from pulmonary or cutaneous focus to virtually any organ.

2.2. Epidemiology and Risk Factors {#sec2.2}
----------------------------------

Nocard first described*Nocardia* in 1888 \[[@B1]\] which was later described by Eppinger (1890), in a man with a pulmonary disease with "pseudotuberculosis" of lungs and pleura, caseous peribronchial lymph nodes, meningitis, and multiple abscesses in the brain \[[@B2]\].*Nocardia* consists of more than 22 species of which*N. asteroides* complex, comprising of*N. asteroides* sensu stricto,*N. farcinica*,*N. nova,* and*N. abscessus*, is the most common. Agricultural occupation is a risk factor for pulmonary nocardiosis. Systemic immunosuppression, corticosteroid therapy, lymphoma, sarcoidosis, systemic lupus erythematosus, chronic alcoholism, diabetes mellitus, and human immunodeficiency virus (HIV) infection are other predisposing factors. Lately, it has been observed that COPD is also a risk factor for*Nocardia* infection \[[@B3]\].

2.3. Clinical Presentation {#sec2.3}
--------------------------

Pulmonary nocardiosis can present as acute, subacute, or chronic suppurative infection with a tendency to remit or exacerbate. PN is usually suppurative but granulomatous, or mixed variety may occur. Clinical manifestation includes pneumonia, endobronchial inflammatory masses, lung abscess, and cavitary disease with contiguous extension leading to effusion and empyema.

2.4. Radiological Findings {#sec2.4}
--------------------------

Irregular nodules, reticulonodular or diffuse pneumonic infiltrates, and pleural effusions are seen in X-ray. The progressive fibrotic disease may develop following inadequate therapy, and the diagnosis is often difficult. It can be fatal in patients with advanced HIV infection and often presents as alveolar infiltrates rather than cavitary lesion. In this situation, the X-ray findings are nonspecific and hence should be considered as a differential diagnosis of indolent pulmonary disease along with*Mycobacteria*,*Actinomyces*, and Eumycetes (*Cryptococcus neoformans* and*Aspergillus* species).

2.5. Laboratory Diagnosis {#sec2.5}
-------------------------

Demonstration of*Nocardia* in clinical sample clinches the diagnosis. Direct demonstration of*Nocardia* from sputum, bronchoalveolar lavage, bronchial aspirate, or endotracheal aspirate should be attempted.

Gram\'s stain smear shows Gram-positive, beaded, fine, right-angled branching filaments (\<1 *μ*m diameter) which may fragment to form rods and coccoid forms of varying sizes. Most isolates of*Nocardia* are acid fast by modified Kinyoun technique that differentiates it from*Actinomyces* which is not acid fast. Silver methenamine stain is equally useful and reliable as modified Ziehl-Neelsen staining \[[@B4]\].

*Nocardia* spp. grow on media used for culture of bacteria, fungi, and*Mycobacteria*. Typical colonies appear after three to five days.*Nocardia* spp. appear as either buff or pigmented waxy cerebriform colonies or have a dry, chalky-white appearance with the production of aerial hyphae.

Some commercial identification systems like API 20C (Biomerieux) allow for rapid identification of*Nocardia* spp. but have the limitation of the traditional phenotypic method \[[@B5]\].

Molecular identification of*Nocardia* is not only quick and accurate but also helps in the recognition of new species. Various methods like ribotyping, polymerase chain reaction, restriction fragment length polymorphism analysis, and DNA sequencing are available \[[@B6]\].

DNA sequencing is currently the best tool for species identification of*Nocardia*. Sequencing of first 500--606 base pairs of the 5′ end of 16S rRNA gene is the recommended method \[[@B6]\]. All these methods have their limitations and should be used with caution.

Currently, there are no serological tests available for diagnosis of active nocardiosis due to the cross-reactivity among different*Nocardia* species,*Mycobacterium tuberculosis*,*Mycobacterium leprae,* and other Actinomycetes \[[@B7]\].

2.6. Management {#sec2.6}
---------------

Trimethoprim-sulfamethoxazole (TMP-SMX) is the mainstay of treatment and has improved the outcomes. In adults, with normal renal function and localized disease, the recommended daily dose of TMP-SMX is 5 to 10 mg/kg TMP and 25 to 50 mg/kg SMX in two to four divided doses, depending on the extent of disease. Higher initial doses (15 mg/kg TMP and 75 mg/kg SMX), given intravenously or orally, are frequently used in patients with cerebral abscesses; severe, extensive, or disseminated infection; or AIDS. Sulfonamides are the treatment of choice for disease due to*N. brasiliensis*. However, mortality with monotherapy is as high as 50% \[[@B8]\] especially in severely ill patients and those with cerebral involvement or disseminated nocardiosis and immune-suppression. Empirical combination therapy with amikacin and imipenem (or meropenem) or a three-drug regimen comprising of Sulphonamides, amikacin, and either a Carbapenem or third generation Cephalosporin can be used in such high-risk patients.

3. Conclusion {#sec3}
=============

Isolation of nocardiae from sputum or blood occasionally represents colonization, transient infection, or contamination. In cases of respiratory tract colonization, Gram-stained specimens are usually negative, and cultures are only intermittently positive. Until a better tool to determine the virulence of*Nocardia* is available, the positive culture often reflects disease in immune-suppressed patients, such as patients on corticosteroid therapy, patients who undergo organ transplantation, patients with chronic lung disease, and HIV-positive patients. Therefore, PN must be suspected in patients with these risk factors and positive imaging findings. Early detection of the organism can lead to the prompt initiation of treatment and reduced mortality in these patients. Initial combination therapy with two or more active agents is recommended for patients with disseminated or severe nocardiosis.

Additional Points {#sec4}
=================

*Learning Objectives.* (i) To recognize the importance of*Nocardia* in causing lung infections. (ii) To diagnose*Nocardia* in the laboratory. (iii) To treat infections caused by*Nocardia*.

*Pre-Test.* (1) How to diagnose Pulmonary Nocardiosis? (2) How can it be treated effectively?

*Post-Test*

*(1) How to Diagnose Pulmonary Nocardiosis?* Direct demonstration of*Nocardia* from clinical samples stained with Gram\'s stain and the modified acid fast stain will help in the diagnosis of Nocardiosis.*Nocardia* appears as Gram-positive filamentous branching rods with beaded appearance on Gram\'s staining and acid fast branching filamentous rods with beaded appearance on modified Ziehl-Neelsen staining. The diagnosis can further be confirmed by culturing the organism in solid media.

*(2) How Can It Be Treated Effectively?* Trimethoprim-sulfamethoxazole (TMP-SMX) is the mainstay of treatment. However, monotherapy may lead to treatment failures. Hence, empirical combination therapy with amikacin and imipenem (or meropenem) or a three-drug regimen comprising Sulphonamides, amikacin, and either a Carbapenem or third generation Cephalosporin can be used in high-risk patients.
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Details of patients with pulmonary nocardiosis.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                Case 1                                                                                                Case 2                                                                                                   Case 3                                                Case 4                                                                                                                                                                Case 5
  ----------------------------- ----------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------- ----------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------
  Age                           76                                                                                                    70                                                                                                       57                                                    70                                                                                                                                                                    42

  Diagnosis                     COPD with pulmonary T.B.                                                                              COPD with pulmonary T.B.                                                                                 COPD with DM                                          Treated pulmonary T.B.                                                                                                                                                Treated pulmonary T.B.

  H/o ATT                       Yes                                                                                                   Yes                                                                                                      No                                                    Yes                                                                                                                                                                   Yes

  H/O DM                        No                                                                                                    No                                                                                                       Yes                                                   No                                                                                                                                                                    No

  HIV                           No                                                                                                    No                                                                                                       No                                                    No                                                                                                                                                                    No

  H/O smoking                   Yes                                                                                                   Yes                                                                                                      Yes                                                   No                                                                                                                                                                    No

  COPD                          Yes                                                                                                   Yes                                                                                                      Yes                                                   No                                                                                                                                                                    No

  Chief complaints              Breathlessness and increased cough with sputum for 4-5 days and loss of weight and loss of appetite   Breathlessness and cough with sputum for 20 years acutely increased for two weeks and fever for 1 week   Breathlessness and cough with sputum for 15 days      Breathlessness and cough with sputum for three months, intermittent fever for three months, and loss of weight                                                        Persistent symptoms of fever, loss of appetite, and mucopurulent sputum for two months after ATT course

  X-ray                         Bilateral pneumonia                                                                                   Bilateral pneumonia                                                                                      ---                                                   Rt lower zone opacity                                                                                                                                                 Left lower lobe collapse with consolidation

  Clinical samples              Sputum                                                                                                Sputum                                                                                                   Sputum                                                Sputum                                                                                                                                                                BAL, BA, and sputum

  SMEAR Grams                   Gram positive branching filamentous rods with beads                                                   Gram positive branching filamentous rods with beads                                                      Gram positive branching filamentous rods with beads   Gram positive branching filamentous rods with beads                                                                                                                   Gram positive branching filamentous rods with beads

  Modified acid fast staining   Acid fast branching filamentous rods with beads                                                       Acid fast branching filamentous rods with beads                                                          Acid fast branching filamentous rods with beads       Acid fast branching filamentous rods with beads                                                                                                                       Acid fast branching filamentous rods with beads

  Culture on sheep blood agar   Positive after 48 hrs of incubation                                                                   Positive after 48 hrs of incubation                                                                      Culture-negative after seven days of incubation       Positive after three days of incubation                                                                                                                               Positive after 48 hrs of incubation

  Treatment                     T. Septran 4 days\                                                                                    T. TMP-SMX 20 days\                                                                                      T. TMP-SMX 5 days\                                    Inj Amikacin 2 weeks\                                                                                                                                                 Inj Amikacin 2 weeks\
                                Inj Amikacin 4 days\                                                                                  Inj Amikacin 2 wks\                                                                                      Inj Amikacin 5 days\                                  T. TMP-SMX 4 months                                                                                                                                                   T. TMP-SMX 4 months
                                Inj Imipenem 4 days                                                                                   Inj Meropenem 10 days                                                                                    T. Voriconazole 5 days                                                                                                                                                                                                      

  Outcome                       Patient expired after six days of admission                                                           Discharged with advice to continue TMP-SMX for six months and to come for follow-up                      Patient expired after six days of admission           Sputum negative after a week. Discharged with advice to continue TMP-SMX for six months and to come for follow-up                                                     Sputum was negative after one wk of treatment. Discharged with advice to continue TMP-SMX for six mths and to come for follow-up

  Follow-up                     ---                                                                                                   The patient was lost to follow-up                                                                        ---                                                   Sputum samples taken at one and two months of follow-up were negative. Complete resolution of the lesion at four months of treatment with TMP-SMX and no complaints   Smear-negative after seven days and after two weeks follow-up
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

COPD: chronic obstructive pulmonary disease.

ATT: antituberculous treatment.

DM: diabetes mellitus.

TMP-SMX: trimethoprim-sulfamethoxazole.

T.B.: tuberculosis.
